ICPT Annual Accounts Payable
$14.23 M
-$3.36 M-19.12%
31 December 2022
Summary:
As of February 5, 2025, ICPT annual accounts payable is $14.23 million, with the most recent change of -$3.36 million (-19.12%) on December 31, 2022. During the last 3 years, it has fallen by -$4.74 million (-24.99%).ICPT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Quarterly Accounts Payable
$10.27 M
+$10.18 M+11978.82%
30 September 2023
Summary:
As of February 5, 2025, ICPT quarterly accounts payable is $10.27 million, with the most recent change of +$10.18 million (+11978.82%) on September 30, 2023. Over the past year, it has dropped by -$11.04 million (-51.80%).ICPT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICPT Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.1% | -51.8% |
| 3 y3 years | -25.0% | -33.6% |
| 5 y5 years | +104.4% | +48.3% |
ICPT Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -42.1% | -78.1% |
Intercept Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $10.27 M(>+9900.0%) |
| June 2023 | - | $85.00 K(-99.3%) |
| Mar 2023 | - | $12.74 M(-10.5%) |
| Dec 2022 | $14.23 M(-19.1%) | $14.23 M(-33.2%) |
| Sept 2022 | - | $21.30 M(+82.6%) |
| June 2022 | - | $11.67 M(+12.3%) |
| Mar 2022 | - | $10.39 M(-41.0%) |
| Dec 2021 | $17.60 M(-28.4%) | $17.60 M(+18.0%) |
| Sept 2021 | - | $14.91 M(-1.2%) |
| June 2021 | - | $15.09 M(+19.9%) |
| Mar 2021 | - | $12.58 M(-48.8%) |
| Dec 2020 | $24.59 M(+29.6%) | $24.59 M(+59.0%) |
| Sept 2020 | - | $15.47 M(-44.8%) |
| June 2020 | - | $28.02 M(+87.1%) |
| Mar 2020 | - | $14.98 M(-21.1%) |
| Dec 2019 | $18.98 M(+61.3%) | $18.98 M(-2.6%) |
| Sept 2019 | - | $19.48 M(-0.8%) |
| June 2019 | - | $19.65 M(+5.8%) |
| Mar 2019 | - | $18.58 M(+57.9%) |
| Dec 2018 | $11.77 M(+68.9%) | $11.77 M(+70.0%) |
| Sept 2018 | - | $6.92 M(-26.0%) |
| June 2018 | - | $9.35 M(-31.0%) |
| Mar 2018 | - | $13.54 M(+94.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $6.96 M(+3.6%) | $6.96 M(-30.7%) |
| Sept 2017 | - | $10.05 M(-23.9%) |
| June 2017 | - | $13.21 M(+81.4%) |
| Mar 2017 | - | $7.28 M(+8.3%) |
| Dec 2016 | $6.72 M(+61.2%) | $6.72 M(-85.7%) |
| Sept 2016 | - | $46.85 M(+9.7%) |
| June 2016 | - | $42.69 M(+0.5%) |
| Mar 2016 | - | $42.47 M(+918.5%) |
| Dec 2015 | $4.17 M(+33.3%) | $4.17 M(-86.3%) |
| Sept 2015 | - | $30.40 M(+38.1%) |
| June 2015 | - | $22.01 M(+34.4%) |
| Mar 2015 | - | $16.37 M(+423.2%) |
| Dec 2014 | $3.13 M(-2.1%) | $3.13 M(-78.7%) |
| Sept 2014 | - | $14.71 M(+45.1%) |
| June 2014 | - | $10.14 M(+15.7%) |
| Mar 2014 | - | $8.76 M(+174.2%) |
| Dec 2013 | $3.20 M(+170.8%) | $3.20 M(+130.9%) |
| Sept 2013 | - | $1.38 M(+67.6%) |
| June 2013 | - | $826.00 K(-38.4%) |
| Mar 2013 | - | $1.34 M(+13.6%) |
| Dec 2012 | $1.18 M(+95.4%) | $1.18 M(+12.6%) |
| Sept 2012 | - | $1.05 M(-4.8%) |
| June 2012 | - | $1.10 M(+82.3%) |
| Dec 2011 | $604.00 K | $604.00 K |
FAQ
- What is Intercept Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals annual accounts payable year-on-year change?
- What is Intercept Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Intercept Pharmaceuticals?
- What is Intercept Pharmaceuticals quarterly accounts payable year-on-year change?
What is Intercept Pharmaceuticals annual accounts payable?
The current annual accounts payable of ICPT is $14.23 M
What is the all time high annual accounts payable for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high annual accounts payable is $24.59 M
What is Intercept Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, ICPT annual accounts payable has changed by -$3.36 M (-19.12%)
What is Intercept Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of ICPT is $10.27 M
What is the all time high quarterly accounts payable for Intercept Pharmaceuticals?
Intercept Pharmaceuticals all-time high quarterly accounts payable is $46.85 M
What is Intercept Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, ICPT quarterly accounts payable has changed by -$11.04 M (-51.80%)